Correlative effect between sac regression and patient longevity following endovascular solution for abdominal aortic aneurysms: an international analysis
Restricted accessResearch articleFirst published online September, 2023
Correlative effect between sac regression and patient longevity following endovascular solution for abdominal aortic aneurysms: an international analysis
Since the introduction of endovascular aortic repair (EVAR) it has become the mainstay treatment for abdominal aortic aneurysms. Several EVAR devices exist commercially, yet, the Terumo Aortic Fenestrated Anaconda™ endograft has demonstrated outstanding results. Evidence in the literature suggests that sac regression could be linked to patient survival and longevity. The main scope of this study is to evaluate sac regression and survival achieved using the Fenestrated Anaconda™ endograft and to discuss relevant literature.
Materials and methods
The current study represents a nine-year cross-sectional international analysis of custom-made Fenestrated Anaconda™ device. For the statistical analysis, SPSS 28 for Windows and R were utilised. Pearson chi-square analysis was used to assess differences in cumulative distribution frequencies between select variables. Statistical significance for all two-tailed tests was set at p < 0.05.
Results
A total of 5,058 patients received the Fenestrated Anaconda™ in this study, either due to unsuitable/complex anatomy for competitor devices (n = 3,891) or based on surgeon preference (n = 1,167). A sac regression of 0–30% was observed in 4,772 (94.3%) over the first four years post-EVAR. Here, 99.6% of patients receiving the Fenestrated Anaconda™ due to unsuitable/complex anatomy for competitor devices and 76.8% based on surgeon preference had 0–30% sac regression. During years 5–9 of follow-up, all patients had 20–45% sac regression. Patient survival during the first six years post-EVAR was 100% but dropped to 77.1% in years 7–9. Survival differed between categorical patient subsets based on the indication.
Discussion
The Fenestrated Anaconda™ has been proven to be a highly effective EVAR endograft. Evidence in the literature clearly demonstrates that sac regression is an accurate prognostic factor for patient survival and longevity.
HirschATHaskalZJHertzerNR, et al.ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation2006; 113: e463–e654.
2.
KühnlAErkATrennerM,et al.Incidence, treatment and mortality in patients with abdominal aortic aneurysms. Dtsch Arztebl Int2017; 114: 391–398.
3.
BoyleJRGoodallSThompsonJP,et al.Endovascular AAA repair attenuates the inflammatory and renal responses associated with conventional surgery. J Endovasc Ther2000; 7: 359–371.
4.
DuaAKuySLeeCJ,et al.Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010. J Vasc Surg2014; 59: 1512–1517.
5.
LederleFAKyriakidesTCStroupeKT, et al. Open versus endovascular repair of abdominal aortic aneurysm. N Engl J Med2019; 380: 2126–2135.
6.
BlankensteijnJDde JongSECAPrinssenM, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med2005; 352: 2398–2405. doi:10.1056/NEJMoa051255
7.
EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet Lond Engl2005; 365: 2179–2186. doi:10.1016/S0140-6736(05)66627-5
8.
LiMSternJTranK,et al.Predictors of sac regression after fenestrated endovascular aneurysm repair. Eur J Vasc Endovasc Surg2022; 63: e20–e21.
9.
AhnSSRutherfordRBJohnstonKW, et al. Reporting standards for infrarenal endovascular abdominal aortic aneurysm repair. Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg1997; 25: 405–410.
10.
O’DonnellTFXDeerySEBoitanoLT, et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg2019; 69: 414–422.
11.
JettyPHusereauDKansalV,et al.Variability in aneurysm sac regression after endovascular aneurysm repair based on a comprehensive registry of patients in eastern ontario. J Vasc Surg2019; 70: 1469–1478.
12.
IserniaGSimonteGMichelagnoliS, et al. Nineteen-year outcomes with the anaconda stent graft system from two tertiary centers [published correction appears in J Vasc Surg. 2022 Jun;75(6):2104]. J Vasc Surg2021; 74: 105–113.
13.
RödelSGGeelkerkenRHPrescottRJ, et al. The anaconda AAA stent graft system: 2-year clinical and technical results of a multicentre clinical evaluation. Eur J Vasc Endovasc Surg2009; 38: 732–740.
14.
DemangetNDupreyABadelP, et al. Finite element analysis of the mechanical performances of 8 marketed aortic stent-grafts. J Endovasc Ther2013; 20: 523–535.
15.
FreyrieAGargiuloMRossiC, et al. Preliminary results of anaconda aortic endografts: a single center study. Eur J Vasc Endovasc Surg2007; 34: 693–698.
16.
MidyDBecqueminJPMialheC, et al. Results of the French multicentric study of ANACONDATM fenestrated endografts in the treatment of complex aortic pathologies (EFEFA registry). Ann Vasc Surg2017; 43: 151–165. doi:10.1016/j.avsg.2017.03.171
17.
StehrASchnitzbauerAASteinbauerMG, et al. Early experience shows rapid shrinking of abdominal aortic aneurysms after endovascular treatment with anaconda device. Vasa2007; 36: 199–204.
18.
FreyrieAGallittoEGargiuloM, et al. Results of the endovascular abdominal aortic aneurysm repair using the anaconda aortic endograft. J Vasc Surg2014; 60: 1132–1139.
19.
ShahverdyanRGrayDGawendaM,et al.Single centre results of total endovascular repair of complex aortic aneurysms with custom made anaconda fenestrated stent grafts. Eur J Vasc Endovasc Surg2016; 52: 500–508.
20.
de NietAZeebregtsCJReijnenMMPJ,et al.Outcomes after treatment of complex aortic abdominal aneurysms with the fenestrated anaconda endograft. J Vasc Surg2020; 72: 25–35.e1.
21.
KotelisDSchleimerKFoldenauerC, et al. Operative and midterm outcomes of the fenestrated anaconda stent-graft in the endovascular treatment of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms. J Endovasc Ther2016; 23: 930–935.
22.
HaiderSENajjarSFChoJS, et al. Sac behavior after aneurysm treatment with the gore excluder low-permeability aortic endoprosthesis: 12-month comparison to the original excluder device. J Vasc Surg2006; 44: 694–700.
23.
HoggMEMoraschMDParkT,et al.Long-term sac behavior after endovascular abdominal aortic aneurysm repair with the excluder low-permeability endoprosthesis. J Vasc Surg2011; 53: 1178–1183.
24.
VedaniSMPetitprezSWeinzE, et al. Predictors and consequences of sac shrinkage after endovascular infrarenal aortic aneurysm repair. J Clin Med2022; 11: 3232.
25.
AntoniouGAAlfahadAAntoniouSA,et al.Prognostic significance of aneurysm sac shrinkage after endovascular aneurysm repair. J Endovasc Ther2020; 27: 857–868.
26.
SaratzisNMelasNSaratzisA, et al. Anaconda aortic stent-graft: single-center experience of a new commercially available device for abdominal aortic aneurysms. J Endovasc Ther2008; 15: 33–41. doi:10.1583/07-2277.1
27.
KarkosCDKapetaniosDMAnastasiadisPTh, et al. Endovascular repair of abdominal aortic aneurysms with the AnacondaTM stent graft: mid-term results from a single center. Cardiovasc Intervent Radiol2015; 38: 1416–1424. doi:10.1007/s00270-015-1081-8
28.
DijkstraMLTielliuIFJMeerwaldtR, et al. Dutch Experience with the fenestrated anaconda endograft for short-neck infrarenal and juxtarenal abdominal aortic aneurysm repair. J Vasc Surg2014; 60: 301–307. doi:10.1016/j.jvs.2014.02.011
29.
RödelSGJZeebregtsCJHuismanAB,et al.Results of the anaconda endovascular graft in abdominal aortic aneurysm with a severe angulated infrarenal neck. J Vasc Surg2014; 59: 1495–1501, 1501.e1. doi:10.1016/j.jvs.2013.12.034
30.
RollsAEJenkinsMBicknellCD, et al. Experience with a novel custom-made fenestrated stent graft in the repair of juxtarenal and type IV thoracoabdominal aneurysms. J Vasc Surg2014; 59: 615–622. doi:10.1016/j.jvs.2013.10.038
31.
VerziniFRomanoLParlaniG, et al. Fourteen-year outcomes of abdominal aortic endovascular repair with the zenith stent graft. J Vasc Surg2017; 65: 318–329. doi:10.1016/j.jvs.2016.07.117
32.
VäärämäkiSSaleniusJPPimenoffG,et al.Systematic long-term follow up after endovascular abdominal aortic aneurysm repair with the zenith stent graft. Eur J Vasc Endovasc Surg2019; 58: 182–188. doi:10.1016/j.ejvs.2019.03.006
33.
KawamataHTajimaHUedaT, et al. Long-term outcomes of endovascular aortic aneurysm repair with the zenith AAA endovascular graft: a single-center study. Jpn J Radiol2020; 38: 77–84. doi:10.1007/s11604-019-00892-6
34.
OderichGSFarberMASchneiderD, et al. Final 5-year results of the United States Zenith fenestrated prospective multicenter study for juxtarenal abdominal aortic aneurysms. J Vasc Surg2021; 73: 1128–1138.e2. doi:10.1016/j.jvs.2020.08.128
35.
EspinosaGRibeiro AlvesMFerreira CaramalhoM,et al.A 10-year single-center prospective study of endovascular abdominal aortic aneurysm repair with the talent stent-graft. J Endovasc Ther2009; 16: 125–135.
36.
W‘t MannetjeYWBroosPPvan PoppelRF,et al.Late single-center outcome of the talent abdominal stent graft after a decade of follow-up. J Vasc Surg2016; 64: 557–562.
37.
SalemansPBLindRCvan der LindeRA,et al.Up to 10-year follow-up after EVAR with the endurant stent graft system: a single-center experience. J Cardiovasc Surg (Torino)2021; 62: 242–249.
38.
PoublonCGHolewijnSvan SterkenburgSMM,et al.Long-Term outcome of the GORE EXCLUDER AAA endoprosthesis for treatment of infrarenal aortic aneurysms. J Vasc Interv Radiol2017; 28: 637–644.e1.
